Jared Kaltwasser


Personalized Solutions Boost Medication Adherence

For the past 20 to 25 years, data has shown that half of patients prescribed long-term medications do not take them as prescribed.

Neal Bhatia, MD


Frontline Forum Part 5: A Discussion of the Current Treatment Landscape for Atopic Dermatitis

In part 5 of this Frontline Forum, Raj Chovatiya, MD, PhD; Neal D. Bhatia, MD; Alexandra K. Golant, MD; and Brett King, MD, PhD, discuss the rapidly changing use for JAK inhibitors and other agents for atopic dermatitis.

Joseph F. Merola, MD, MMSc


Psoriasis Case Impressions

Mark G. Lebwohl, MD, and Joseph F. Merola, MD, MMSc, provide impressions to the case and take-home messages for dermatologists and rheumatologists treating psoriasis.

Connor Iapoce


Malignancy Risk Low in Secukinumab Treatment

A study finds low risk of malignancy from secukinumab treatment for psoriasis, psoriatic arthritis and ankylosing spondylitis patients, despite limited data.

Alan Menter, MD


Continuing Medical Education: Three Things to Know About Pustular Psoriasis

Pustular psoriasis (PP) is a rare and potentially serious inflammatory skin disorder affecting about 1% of patients with psoriasis.

Miranda Hester


Amy Paller, MD, Discusses Long-Term Safety and Efficacy of Ixekizumab in Kids

Paller discusses the findings of the clinical trial examining the long-term effects of ixekizumab for treating psoriasis in children.

Pahroul Davé, APN


The Dx and Rx of Congenital Malalignment Syndrome in Children

Congenital malalignment syndrome is a nail disorder caused by the lateral rotation of the nail matrix.

Laura Joszt, MA


Real-World Study Shows Dupixent Improves AD Symptoms in Children Under 12 Years

A real-world study of children with moderate-to-severe atopic dermatitis (AD) in China found Dupixent can reduce symptoms and improve pruritus. Traditional therapies had little effect, according to the researchers.

Patty Weasler


Pulsed Dye Lasers for Cosmetic Procedures

Pulsed dye lasers are now being used for several different dermatologic conditions.

Omar A. Ibrahimi, MD, PhD


New Tech for Skin

There are many innovative and exciting developments coming to the dermatology space, both energy-based devices and injectables.

Bernard A. Cohen, MD


Treatment of Plaque Psoriasis in Children

A variety of topicals and biologics are now available to treat children affected by this challenging condition.

Nicholas Brownstone, MD


Dermatology Drug Pipeline 2023

Breakthroughs and approvals we can expect in the coming year.

Lindsey Carr, Editor


Clinical Considerations for Monkeypox in Pregnancy

What we know about monkeypox in pregnancy, including treatment recommendations, vaccination, and postpartum care.

Jennifer Barrett


FDA approves topical for actinic keratosis

Tirbanibulin (Klisyri, Almirall) has been approved by the U.S. Food and Drug Administration (FDA) for the topical treatment of actinic keratosis on the face or scalp.

Nick Loftin


5 steps to make telehealth work for physicians and patients

There are barriers to telehealth adoption that physicians must overcome to realize the technology’s promise.

Jonathan Alicea


Psoriasis Associated with Increased Risk for Retinal Diseases

More research is needed to understand the pathogenesis underlying this association.

Thy Huynh, MD


Dermatologic differences in a diverse population

Understanding the difference in biology and clinical presentations of cutaneous conditions in different skin types is critical for health care professionals to treat a diverse population.

Marni Jameson Carey


A Health Care Price Transparency Revolution is at Hand

Payers must make public the individual amounts their health plans pay providers across all types of services and locations, including hospitals, doctors’ offices, imaging centers, outpatient surgery centers and urgent care clinics.

Lauren Biscaldi


Opioid Use in Psoriatic Arthritis Is Associated With Higher Health Care Costs, Utilization

New pathways of care are needed to improve health care spending.

Will Kirby, DO, FAOCD


Will Kirby, DO, FAOCD, Talks With Dustin Portela, DO, FAAD

Will Kirby, DO, FAOCD, talks with Dustin Portela, DO, FAAD, about TikTok, what being a KOL really means, and the biggest aesthetic myth in the industry right now.

Nicole A. Negbenebor, MD


Skin of Color Society Summit: An Overview

Hiring investigators of color, educating and building trust with potential participants, and addressing funding can make clinical trials more diverse.

Grace Halsey


Omicron COVID-19 variant: What we know and what we don’t

The Omicron variant of COVID-19 is spreading quickly, jumping continents with infected travelers. Here’s the latest on what global health officials know about it.

Brett King, MD, PhD


Optimizing Patient Outcomes with JAK Inhibitors

Brett King, M.D, Ph.D and Alexandra Golant, M.D summarize their thoughts on optimizing treatment outcomes for patients suffering from atopic dermatitis with the JAK inhibitor class.

Briana Contreras


Non-Invasive Test That May Help Predict Eczema in Babies

Results from the test reveal that high levels of the immune biomarker Thymus and Activation-Regulated Chemokine (TARC) in babies increases their chances of developing atopic dermatitis.

Oriana Lerner


Can Supplements Effectively Manage Hair Loss?

Data presented at the American Academy of Dermatology 2022 Annual Meeting shows what supplements can and cannot manage alopecia areata.

Heidi Moawad, MD


What You Need to Know About Mentoring Doctors

Defining the goals of the mentoring relationship can be useful to clarify expectations.

Christine Pham, PharmD


Clascoterone cream 1% targets androgen receptors

The topical cream is the first acne drug with a new mechanism of action to win FDA approval in the last 40 years.

© 2023 MJH Life Sciences

All rights reserved.